Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring

This publication has 42 references indexed in Scilit:

• Influenza vaccination of recommended adult populations, U.S., 1989–2005
  Vaccine, 2008
• Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
  Expert Review of Vaccines, 2008
• Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
  New England Journal of Medicine, 2006
• Comparing data mining methods on the VAERS database
  Pharmacoepidemiology and Drug Safety, 2005
• The Role of the Vaccine Adverse Event Reporting System (VAERS) in Monitoring Vaccine Safety
  Pediatric Annals, 2004
• Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
  The Pediatric Infectious Disease Journal, 2004
• Risk of Anaphylaxis After Vaccination of Children and Adolescents
  Pediatrics, 2003
• Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens
  Archives of internal medicine (1960), 1998
• The vaccine adverse event reporting system (VAERS)
  Vaccine, 1994
• GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771
  American Journal of Epidemiology, 1979